IABDM backs White House appeal to end mercury fillings and review Casa Pia trial
The International Academy of Biological Dentistry and Medicine is supporting a formal appeal to President Donald Trump that seeks to end new mercury dental amalgam placements, set national removal safety standards and open an independent review of the NIH-funded Casa Pia children’s trial in Portugal. The appeal also asks the White House to preserve records and respond with a federal timeline.
Why it matters: - The appeal targets mercury dental amalgam, a material still used in some dentistry, and seeks to accelerate a federal move away from it. - The request also presses for review of research ethics and safety monitoring in a federally funded pediatric trial that has drawn long-running scrutiny. - IABDM says stronger standards would protect both patients and dental professionals from mercury exposure.
What happened: - IABDM said it supports a formal appeal submitted to President Donald Trump by mercury advocate Anita Tibau. - Tibau asked for an end to new mercury dental amalgam placements, national removal safety standards, and an independent investigation of the NIH-funded Casa Pia children’s dental trial in Portugal. - Tibau said the White House acknowledged receipt of the appeal. - The appeal also calls for federal action on FDA Citizen Petition FDA-2025-P-2526.
The details: - The Casa Pia study, funded under NIH grant U01 DE011894, enrolled 507 children in Lisbon and compared mercury-containing dental amalgam with composite fillings. - In 2002, allegations of sexual abuse involving children at Casa Pia became public, and the dental trial continued afterward. - Tibau says documents obtained through FOIA include a Sept. 15, 1999, Data and Safety Monitoring Board report that documented sentinel events and mercury-related observations. - Tibau argues those issues were not adequately addressed in later publications. - A 2006 JAMA study reported no statistically significant differences in its principal measured neurobehavioral outcomes between the treatment groups. - Tibau is seeking an independent review of the full research and safety record. - The request asks investigators to examine research ethics, informed consent, safety monitoring, the September 1999 report and communications with NIH and FDA. - The appeal also seeks voluntary, independent health assessments and follow-up care for former Casa Pia participants, who are now adults. - IABDM is asking HHS and FDA to pursue the fastest lawful pathway to end routine new mercury amalgam placements nationwide, working with CMS, the Indian Health Service, Veterans Affairs and other federal programs. - IABDM is also urging enforceable national safety rules for amalgam removal based on its PROTECT Protocol. - The protocol emphasizes OSHA respiratory protection requirements, high-volume evacuation, isolation, ventilation, personal protective equipment, staff training and informed patient consent. - IABDM says the PROTECT Protocol is meant to reduce mercury exposure risks for patients, dental professionals and the environment. - The organization says protecting dental professionals from mercury exposure is an occupational safety responsibility, not only a clinical preference. - Tibau also wants independent scrutiny of the American Dental Association’s influence on dental standards of care and regulatory decision-making. - She cites disciplinary proceedings involving biological dentist Dr. Blanche Grube as an example that should be examined.
Between the lines: - The appeal links a public-health argument about mercury exposure with a broader challenge to how dental standards are set and enforced. - The Casa Pia request raises questions about whether federal regulators and trial overseers had complete safety information during and after the study. - IABDM’s support signals continued pressure from mercury-free dentistry advocates for federal intervention, not just professional self-regulation. - The European Union began broadly restricting dental amalgam use in January 2025, with limited exceptions and transition provisions, adding international pressure to the debate. - IABDM has advocated for mercury-free dentistry, biocompatible dental materials and an oral-systemic health approach for more than four decades.
What’s next: - Tibau is asking the White House to preserve Casa Pia research records immediately. - The appeal requests a federal coordinating official within 15 days. - It asks for identification of relevant research and regulatory records within 30 days. - It seeks an interagency action plan within 60 days. - Tibau also wants a written White House response naming responsible offices and concrete next steps. - IABDM says it will continue to back transparency, accountability and stronger protections for patients and dental professionals.
The bottom line: - The appeal puts mercury dentistry, federal oversight and past trial safeguards back in the spotlight, with pressure for both regulatory change and an independent review of the Casa Pia record.
Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.
Sign up for:
News From Europe!
The daily local news briefing you can trust. Every day. Subscribe now.
Check Your Email!
We sent a one-time activation link to: .
Confirm it's you by clicking the email link.
If the email is not in your inbox, check spam or try again.
Welcome back!
is already signed up. Check your inbox for updates.